Table 2.
Characteristic | No. (% of total) | PABAC score Mean (SD) | p value |
---|---|---|---|
Age, years | 0.04 | ||
Mean ± standard deviation | 60.4 ± 11.6 | ||
<60 | 297 (44.9) | 27.3 (4.8) | |
≥60 | 365 (55.1) | 26.3 (5.2) | |
Sex | 0.02 | ||
Male | 231 (34.9) | 26.0 (5.3) | |
Female | 431 (65.1) | 27.2 (4.8) | |
Race | 0.04 | ||
White | 539 (81.4) | 26.6 (5.1) | |
Non-White | 123 (18.6) | 27.9 (4.9) | |
Body Mass Index (kg/m2) | 0.08 | ||
Normal weight (< 25) | 230 (35.0) | 26.2 (5.2) | |
Overweight/Obese (≥ 25) | 428 (65.0) | 27.1 (5.0) | |
Education | 0.03 | ||
High school or less | 212 (32.4) | 27.7 (4.3) | |
Some college or above | 442 (67.6) | 26.5 (5.3) | |
Relationship Status | 0.07 | ||
Partnered | 431 (65.2) | 26.5 (5.1) | |
Not partnered | 230 (34.8) | 27.4 (4.9) | |
Cancer Type | 0.25 | ||
Breast | 206 (31.2) | 27.0 (5.3) | |
Thoracic/Lung | 98 (14.8) | 26.9 (4.6) | |
Hematologic | 97 (14.7) | 25.6 (5.0) | |
Other* | 260 (39.3) | 27.1 (5.0) | |
Cancer Stage | 0.18 | ||
Non-metastatic | 323 (53.2) | 27.1 (5.0) | |
Metastatic | 284 (46.8) | 26.5 (5.0) | |
Time since Cancer Diagnosis | 0.02 | ||
≤ 12 months | 318 (49.6) | 27.4 (4.7) | |
> 12 months | 323 (50.4) | 26.2 (5.3) | |
Cancer Treatment Status | 0.30 | ||
Currently receiving treatment | 501 (80.0) | 27.1 (4.8) | |
Completed treatment | 111 (17.7) | 25.9 (5.7) | |
About to start treatment | 14 (2.3) | 27.1 (5.5) | |
Chemotherapy | 0.24 | ||
Yes | 579 (87.5) | 26.9 (5.1) | |
No | 83 (12.5) | 26.0 (4.8) | |
Radiation | 0.31 | ||
Yes | 352 (53.2) | 26.6 (4.6) | |
No | 310 (46.8) | 27.1 (5.5) | |
Surgery | 0.001 | ||
Yes | 348 (52.6) | 27.6 (5.2) | |
No | 314 (47.4) | 25.9 (4.7) | |
Hospital Treatment Location | 0.03 | ||
Academic | 321 (48.5) | 26.2 (5.2) | |
Community | 341 (51.5) | 27.3 (4.9) | |
Met physical activity recommendations in the past month | <0.001 | ||
Yes | 160 (25.3) | 25.32 (5.9) | |
No | 473 (74.7) | 27.34 (4.6) |
Due to missing data, some variables do not add up to 662.
Other cancer type includes but is not limited to: gastrointestinal, gynecological, genitourinary, head and neck, sarcoma, and skin.